标题
Astragaloside IV: An Effective Drug for the Treatment of Cardiovascular Diseases
作者
关键词
-
出版物
Drug Design Development and Therapy
Volume Volume 14, Issue -, Pages 3731-3746
出版商
Informa UK Limited
发表日期
2020-09-15
DOI
10.2147/dddt.s272355
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Astragaloside IV enhances GATA-4 mediated myocardial protection effect in Hypoxia/Reoxygenation injured H9c2 cells
- (2020) Jing-Jing Yang et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Astragaloside IV attenuates chronic intermittent hypoxia‐induced myocardial injury by modulating Ca 2+ homeostasis
- (2020) Shan Jiang et al. CELL BIOCHEMISTRY AND FUNCTION
- Ischemic Heart Disease and Heart Failure: Role of Coronary Ion Channels
- (2020) Paolo Severino et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Astragaloside IV protects human cardiomyocytes from hypoxia/reoxygenation injury by regulating miR-101a
- (2020) Yang Wu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Protective effects of AS-IV on diabetic cardiomyopathy by improving myocardial lipid metabolism in rat models of T2DM
- (2020) Zhongyuan Wang et al. BIOMEDICINE & PHARMACOTHERAPY
- Anti-tumor effects and mechanisms of Astragalus membranaceus (AM) and its specific immunopotentiation: Status and prospect
- (2020) Shanshan Li et al. JOURNAL OF ETHNOPHARMACOLOGY
- Angiogenic function of astragaloside IV in rats with myocardial infarction occurs via the PKD1‑HDAC5‑VEGF pathway
- (2019) Lei Yang et al. Experimental and Therapeutic Medicine
- Astragaloside IV alleviates heart failure by promoting angiogenesis through the JAK-STAT3 pathway
- (2019) Yan-Bo Sui et al. PHARMACEUTICAL BIOLOGY
- Antioxidant Activities of Quercetin and Its Complexes for Medicinal Application
- (2019) Dong Xu et al. MOLECULES
- Astragaloside IV promotes the eNOS/NO/cGMP pathway and improves left ventricular diastolic function in rats with metabolic syndrome
- (2019) Xin Lin et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Astragaloside IV Regulates the PI3K/Akt/HO-1 Signaling Pathway and Inhibits H9c2 Cardiomyocyte Injury Induced by Hypoxia–Reoxygenation
- (2019) Ping Yang et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Astragaloside IV exerts angiogenesis and cardioprotection after myocardial infarction via regulating PTEN/PI3K/Akt signaling pathway
- (2019) Songyi Cheng et al. LIFE SCIENCES
- Astragaloside IV Exerts a Myocardial Protective Effect against Cardiac Hypertrophy in Rats, Partially via Activating the Nrf2/HO-1 Signaling Pathway
- (2019) Pei Nie et al. Oxidative Medicine and Cellular Longevity
- Astragaloside IV Attenuates Myocardial Ischemia-Reperfusion Injury from Oxidative Stress by Regulating Succinate, Lysophospholipid Metabolism, and ROS Scavenging System
- (2019) Miaomiao Jiang et al. Oxidative Medicine and Cellular Longevity
- Ononin, sec-O-β-d-glucosylhamaudol and astragaloside I: antiviral lead compounds identified via high throughput screening and biological validation from traditional Chinese medicine Zhongjing formulary
- (2019) Yunru Yu et al. PHARMACOLOGICAL RESEARCH
- Astragaloside IV protects cardiomyocytes from hypoxia-induced injury by down-regulation of lncRNA GAS5
- (2019) Jian Du et al. BIOMEDICINE & PHARMACOTHERAPY
- Nutritional preconditioning induced by astragaloside Ⅳ on isolated hearts and cardiomyocytes against myocardial ischemia injury via improving Bcl-2-mediated mitochondrial function
- (2019) Yong Luo et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Astragaloside IV protects against hyperglycemia-induced vascular endothelial dysfunction by inhibiting oxidative stress and Calpain-1 activation
- (2019) Qu Nie et al. LIFE SCIENCES
- Astragaloside IV alleviates myocardial damage induced by type 2 diabetes via improving energy metabolism
- (2019) Zhen Zhang et al. Molecular Medicine Reports
- Astragaloside IV attenuates gestational diabetes mellitus via targeting NLRP3 inflammasome in genetic mice
- (2019) Ruixue Zhang et al. Reproductive Biology and Endocrinology
- Astragaloside IV inhibits cardiac fibrosis via miR-135a-TRPM7-TGF-β/Smads pathway
- (2019) Yanchun Wei et al. JOURNAL OF ETHNOPHARMACOLOGY
- Astragaloside-IV protects H9C2(2-1) cardiomyocytes from high glucose-induced injury via miR-34a-mediated autophagy pathway
- (2019) Yaobin Zhu et al. Artificial Cells Nanomedicine and Biotechnology
- Astragaloside IV Exerts Cardioprotection in Animal Models of Viral Myocarditis: A Preclinical Systematic Review and Meta-Analysis
- (2019) Zhuang Zhuang et al. Frontiers in Pharmacology
- Astragaloside IV attenuates myocardial ischemia/reperfusion injury in rats via inhibition of calcium-sensing receptor-mediated apoptotic signaling pathways
- (2018) Bo Yin et al. ACTA PHARMACOLOGICA SINICA
- Astragaloside IV protects against the pathological cardiac hypertrophy in mice
- (2018) Zhen-hu Liu et al. BIOMEDICINE & PHARMACOTHERAPY
- Astragalosides increase the cardiac diastolic function and regulate the “Calcium sensing receptor-protein kinase C-protein phosphatase 1” pathway in rats with heart failure
- (2018) Yansu Ji et al. BIOMEDICINE & PHARMACOTHERAPY
- Astragaloside IV inhibits ventricular remodeling and improves fatty acid utilization in rats with chronic heart failure
- (2018) Bin Tang et al. BIOSCIENCE REPORTS
- Extract from Astragalus membranaceus inhibit breast cancer cells proliferation via PI3K/AKT/mTOR signaling pathway
- (2018) Ruijuan Zhou et al. BMC Complementary and Alternative Medicine
- Preventive effects of astragaloside IV and its active sapogenin cycloastragenol on cardiac fibrosis of mice by inhibiting the NLRP3 inflammasome
- (2018) Yu Wan et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Mechanisms of physiological and pathological cardiac hypertrophy
- (2018) Michinari Nakamura et al. Nature Reviews Cardiology
- The Role of Saikosaponins in Therapeutic Strategies for Age-Related Diseases
- (2018) Byeong Mo Kim Oxidative Medicine and Cellular Longevity
- MicroRNA-378 suppresses myocardial fibrosis through a paracrine mechanism at the early stage of cardiac hypertrophy following mechanical stress.
- (2018) Jie Yuan et al. Theranostics
- Astragaloside IV Protects Rat Cardiomyocytes from Hypoxia-Induced Injury by Down-Regulation of miR-23a and miR-92a
- (2018) Licheng Gong et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Astragaloside IV improves vascular endothelial dysfunction by inhibiting the TLR4/NF-κB signaling pathway
- (2018) Bin Leng et al. LIFE SCIENCES
- Pharmacokinetics Comparison, Intestinal Absorption and Acute Toxicity Assessment of a Novel Water-Soluble Astragaloside IV Derivative (Astragalosidic Acid, LS-102)
- (2018) Lin-Sen Qing et al. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
- Calcium Sensing Receptor-Related Pathway Contributes to Cardiac Injury and the Mechanism of Astragaloside IV on Cardioprotection
- (2018) Meili Lu et al. Frontiers in Pharmacology
- Astragalus Granule Prevents Ca2+ Current Remodeling in Heart Failure by the Downregulation of CaMKII
- (2017) Sinai Li et al. Evidence-based Complementary and Alternative Medicine
- Sarcoplasmic reticulum Ca 2+ , Mg 2+ , K + , and Cl − concentrations adjust quickly as heart rate changes
- (2017) Claudio Berti et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Inhibition of cardiotrophin-1 overexpression is involved in the anti-fibrotic effect of Astrogaloside IV
- (2017) Guizhi Jia et al. Molecular Medicine Reports
- Astragaloside IV inhibits isoprenaline-induced cardiac fibrosis by targeting the reactive oxygen species/mitogen-activated protein kinase signaling axis
- (2017) Hongliang Dai et al. Molecular Medicine Reports
- Astragaloside attenuates myocardial injury in a rat model of acute myocardial infarction by upregulating hypoxia inducible factor-1α and Notch1/Jagged1 signaling
- (2017) Junmin Yu et al. Molecular Medicine Reports
- AstragalosideⅣ against cardiac fibrosis by inhibiting TRPM7 channel
- (2017) Jun Lu et al. PHYTOMEDICINE
- The effect of different proportions of astragaloside and curcumin on DM model of mice
- (2017) Mingsan Miao et al. SAUDI PHARMACEUTICAL JOURNAL
- Tanshinone IIA and Astragaloside�IV promote the angiogenesis of mesenchymal stem cell-derived endothelial cell-like cells via upregulation of Cx37, Cx40 and Cx43
- (2017) Zhe Li et al. Experimental and Therapeutic Medicine
- Balancing Herbal Medicine and Functional Food for Prevention and Treatment of Cardiometabolic Diseases through Modulating Gut Microbiota
- (2017) Ming Lyu et al. Frontiers in Microbiology
- Targeting Transmembrane BAX Inhibitor Motif Containing 1 Alleviates Pathological Cardiac Hypertrophy
- (2017) Ke-Qiong Deng et al. CIRCULATION
- Astragaloside IV protects cardiomyocytes from anoxia/reoxygenation injury by upregulating the expression of Hes1 protein
- (2016) Huang Huang et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- The Antioxidant Effects of Radix Astragali (Astragalus membranaceus and Related Species) in Protecting Tissues from Injury and Disease
- (2016) Muhammad Shahzad et al. CURRENT DRUG TARGETS
- Astragaloside IV improves the isoproterenol-induced vascular dysfunction via attenuating eNOS uncoupling-mediated oxidative stress and inhibiting ROS-NF-κB pathways
- (2016) Chonghua Xu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Ion Channel Macromolecular Complexes in Cardiomyocytes: Roles in Sudden Cardiac Death
- (2015) H. Abriel et al. CIRCULATION RESEARCH
- Astragaloside IV attenuates apoptosis of hypertrophic cardiomyocyte through inhibiting oxidative stress and calpain-1 activation
- (2015) Meng Mei et al. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
- Effects of Astragaloside IV on the SDF-1/CXCR4 Expression in Atherosclerosis of apoE−/−Mice Induced by Hyperlipaemia
- (2015) Hewei Qin et al. Evidence-based Complementary and Alternative Medicine
- Biological Active Ingredients of Traditional Chinese Herb Astragalus membranaceus on Treatment of Diabetes: A Systematic Review
- (2015) Zhang Kai et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Astragalosides promote angiogenesis via vascular endothelial growth factor and basic fibroblast growth factor in a rat model of myocardial infarction
- (2015) JUN-MIN YU et al. Molecular Medicine Reports
- Cardioprotective and nonprotective regimens of chronic hypoxia diversely affect the myocardial antioxidant systems
- (2015) Dita Kasparova et al. PHYSIOLOGICAL GENOMICS
- Astragaloside IV Attenuates Injury Caused by Myocardial Ischemia/Reperfusion in Rats via Regulation of Toll-Like Receptor 4/Nuclear Factor-κB Signaling Pathway
- (2015) Meili Lu et al. PHYTOTHERAPY RESEARCH
- Astragaloside IV Protects against Isoproterenol-Induced Cardiac Hypertrophy by Regulating NF-κB/PGC-1α Signaling Mediated Energy Biosynthesis
- (2015) Suping Zhang et al. PLoS One
- Astragaloside IV ameliorates diabetic nephropathy involving protection of podocytes in streptozotocin induced diabetic rats
- (2014) Jianguo Chen et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- A Review of Recent Research Progress on the Astragalus Genus
- (2014) Xiaoxia Li et al. MOLECULES
- Review of the Botanical Characteristics, Phytochemistry, and Pharmacology ofAstragalus membranaceus(Huangqi)
- (2014) Juan Fu et al. PHYTOTHERAPY RESEARCH
- HIF-1α Signaling Activation by Post-Ischemia Treatment with Astragaloside IV Attenuates Myocardial Ischemia-Reperfusion Injury
- (2014) Jingwen Si et al. PLoS One
- Cardiac Metabolism and its Interactions With Contraction, Growth, and Survival of Cardiomyocytes
- (2013) Stephen C. Kolwicz et al. CIRCULATION RESEARCH
- Antitumor and immunomodulatory activity of Astragalus membranaceus polysaccharides in H22 tumor-bearing mice
- (2013) Bin Yang et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Extracts from Astragalus membranaceus limit myocardial cell death and improve cardiac function in a rat model of myocardial ischemia
- (2013) Xu Ma et al. JOURNAL OF ETHNOPHARMACOLOGY
- Astragaloside IV attenuates inflammatory cytokines by inhibiting TLR4/NF-кB signaling pathway in isoproterenol-induced myocardial hypertrophy
- (2013) Juan Yang et al. JOURNAL OF ETHNOPHARMACOLOGY
- Astragaloside IV protects heart from ischemia and reperfusion injury via energy regulation mechanism
- (2013) Lei Tu et al. MICROCIRCULATION
- Synergistic Promotion of Blood Vessel Regeneration by Astragaloside IV and Ferulic Acid from Electrospun Fibrous Mats
- (2013) Huan Wang et al. MOLECULAR PHARMACEUTICS
- Astragaloside IV Protects against Cardiac Hypertrophy via Inhibiting the Ca2+/CaN Signaling Pathway
- (2013) Meili Lu et al. PLANTA MEDICA
- Flavonoid constituents and biological screening ofAstragalus bombycinusBoiss.
- (2012) Lamyaa F. Ibrahim et al. NATURAL PRODUCT RESEARCH
- Astragaloside IV Alleviates Hypoxia/Reoxygenation-Induced Neonatal Rat Cardiomyocyte Injury via the Protein Kinase A Pathway
- (2012) Da-Wei Zhang et al. PHARMACOLOGY
- Astragaloside IV attenuates myocardial fibrosis by inhibiting TGF-β1 signaling in coxsackievirus B3-induced cardiomyopathy
- (2011) Ping Chen et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Astragaloside IV inhibits adenovirus replication and apoptosis in A549 cellsin vitro
- (2011) Lei Shang et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Astragaloside IV Improves Metabolic Syndrome and Endothelium Dysfunction in Fructose-Fed Rats
- (2011) Ning Zhang et al. MOLECULES
- Astragaloside IV Improves Homocysteine-Induced Acute Phase Endothelial Dysfunction via Antioxidation
- (2010) Li-Hong Qiu et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- ASTRAGALOSIDE IV ATTENUATES HYPOXIA-INDUCED CARDIOMYOCYTE DAMAGE IN RATS BY UPREGULATING SUPEROXIDE DISMUTASE-1 LEVELS
- (2009) Jiong-Yu Hu et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Astragaloside IV Improved Intracellular Calcium Handling in Hypoxia-Reoxygenated Cardiomyocytes via the Sarcoplasmic Reticulum Ca2+-ATPase
- (2008) Xiao-Le Xu et al. PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search